Naoko P. Kato(@NaokoPKato1) 's Twitter Profile Photo

Grateful to present our results on and (handheld ultrasound) for patients in at 🇵🇹!

Many thanks to Josefine and Pernilla from Capio Johannelund primary care centre, and our team members for the wonderful support🤗

Grateful to present our results on #ReDS and #Vscan (handheld ultrasound) for #heartfailure patients in #primarycare at #HeartFailure2024 🇵🇹!

Many thanks to Josefine and Pernilla from Capio Johannelund primary care centre, and our #LiU team members for the wonderful support🤗
account_circle
Jozine ter Maaten(@jozinetm) 's Twitter Profile Photo

📣 First from : Timing of cardio-kidney protection with inhibitors ⏰
⭐️ across cardio kidney cohorts HF hospitalization presents an early and modifiable event with SGLT2
ahajournals.org/doi/abs/10.116…

📣 First #LBCT from #HeartFailure2024: Timing of cardio-kidney protection with #SGLT2 inhibitors ⏰
⭐️ across cardio kidney cohorts HF hospitalization presents an early and modifiable event with SGLT2 
ahajournals.org/doi/abs/10.116…
account_circle
Área del Corazón del HUVV de Málaga(@ACorazonHUVV) 's Twitter Profile Photo

👩‍⚕️Nuestra residente, Lucía Palma, presenta el trabajo: Clinical, prognosis and economic outcomes in a novel cardio-renal-metabolic unit en

👩‍⚕️Nuestra residente, Lucía Palma, presenta el trabajo: Clinical, prognosis and economic outcomes in a novel cardio-renal-metabolic unit en #HeartFailure2024
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease ( MIRACLE)

Non-significant reductions in ACR with balcinrenone plus dapagliflozin observed with no dose response

Muthu Vaduganathan

#HeartFailure2024

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease ( MIRACLE)

Non-significant reductions in ACR with balcinrenone plus dapagliflozin observed with no  dose response 

@mvaduganathan
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



CD8+ Cytotoxic T-cells Drive Outcome in Chronic Inflammator Cardiomyopathy

unexplored role of CD8+ T-cells in InfI-CMP

Selectively targeting the CD8+ T-cell population may further benefit the treatment of Infl-CMP patients

#HeartFailure2024

CD8+ Cytotoxic T-cells Drive Outcome in Chronic Inflammator Cardiomyopathy

unexplored role of CD8+ T-cells in InfI-CMP

Selectively targeting the CD8+ T-cell population may further benefit the treatment of Infl-CMP patients
account_circle
Alexandra Henry (Gamard)(@agamard_esc) 's Twitter Profile Photo

Straight out of , it’s time to launch the JOURNAL CLUB

1st edition is on 5 JUNE 6PM CEST will discuss: the PUSH-AHF trial

Register now: bit.ly/44J2jxw

Straight out of #HeartFailure2024, it’s time to launch the #HFA_ESC #HFA_YOUNG JOURNAL CLUB 

1st edition is on 5 JUNE 6PM CEST will discuss: the PUSH-AHF trial 

Register now: bit.ly/44J2jxw
account_circle
David Couto Mallón(@david_cm_) 's Twitter Profile Photo

Aficamten for the treatment of symptomatic oHCM. A new kid in the block showing significant improvement in symptoms, exercise capacity and quality of life compared to placebo in oHCM patients 👏🏻👏🏻👏🏻 European Society of Cardiology

Aficamten for the treatment of symptomatic oHCM.  A new kid in the block showing significant improvement in symptoms, exercise capacity and quality of life compared to placebo in oHCM patients 👏🏻👏🏻👏🏻#HeartFailure2024 #sequoia_hcm @escardio
account_circle
Tomo(@tomo_cardiology) 's Twitter Profile Photo

少し遅くなったけど、初めて国際学会で発表した。英語はどこまで伝わったかはわからない。ただ国際学会のプレゼンター、座長はよくわからない東洋人の発表を親身に聞いてくれているのがよく伝わった。それだけでこの地にきた甲斐があった。

少し遅くなったけど、初めて国際学会で発表した。英語はどこまで伝わったかはわからない。ただ国際学会のプレゼンター、座長はよくわからない東洋人の発表を親身に聞いてくれているのがよく伝わった。それだけでこの地にきた甲斐があった。
#HeartFailure2024 #Lisbon
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



Diuresis Efficacy in Ambulatory Chronic Heart Failure Patients:
Intra-Patient Comparison of Three Diuretic Regimens (DEA-HF Clinical Trial)

Intravenous furosemide plus metolazone resulted in a significantly higher natriuresis when compared to IV furosemide

#HeartFailure2024

Diuresis Efficacy in Ambulatory Chronic Heart Failure Patients:
Intra-Patient Comparison of Three Diuretic Regimens (DEA-HF Clinical Trial)

Intravenous furosemide plus metolazone resulted in a significantly higher natriuresis when compared to IV furosemide
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



PRAISE HFpEF DM
Glucagon-like Peptide-1 Receptor Agonist In obeSE Heart Failure with Preserved Ejection Fraction with type 2 diabetes

In DM and obese HFpEF, GLP1-RA at diabetes management associated with reduction in the composite of HFH and mortality

#HeartFailure2024

PRAISE HFpEF DM
Glucagon-like Peptide-1 Receptor Agonist In obeSE Heart Failure with Preserved Ejection Fraction with type 2 diabetes

In DM and obese HFpEF, GLP1-RA at diabetes management associated with reduction in the composite of HFH and mortality
account_circle
CSANZ(@thecsanz) 's Twitter Profile Photo

Check out the highlights in Heart Failure for in Perth - early-bird closing Monday 3 June. Watch video👉bit.ly/3R3AVod
Register Now!👉csanzasm.com
David Playford Dr Girish Dwivedi

Check out the highlights in Heart Failure for #CSANZ2024 in Perth - early-bird closing Monday 3 June. Watch video👉bit.ly/3R3AVod
Register Now!👉csanzasm.com 
#CardioTwitter @PlayfordDavid @cardiacimager  #heartfailure2024
account_circle